Curcumin reverses the epithelial-mesenchymal transition of pancreatic cancer cells by inhibiting the Hedgehog signaling pathway
- PMID: 23563640
- DOI: 10.3892/or.2013.2385
Curcumin reverses the epithelial-mesenchymal transition of pancreatic cancer cells by inhibiting the Hedgehog signaling pathway
Abstract
Curcumin, a phenolic compound extracted from Zingiberaceae turmeric, has strong anti-inflammatory, antioxidant and antitumor properties. However, the anticarcinogenic mechanism of curcumin has yet to be fully elucidated. Epithelial-mesenchymal transition (EMT) induced by transforming growth factor-β1 (TGF-β1) is involved in the promotion of tumor invasion and metastasis, and is closely related to the drug resistance of tumor cells. The abnormal activation of Hedgehog signaling also plays an important role in tumorigenesis and metastasis. In order to investigate whether curcumin can reverse the TGF-β1-stimulated EMT of pancreatic cancer PANC-1 cells, and its possible mechanism, the pancreatic cancer cell line PANC-1 was stimulated with TGF-β1 (5 ng/ml) for 7 days to induce formation of EMT, and the TGF-β1-stimulated PANC-1 cells were treated with different concentrations of curcumin (10, 20 and 30 µmol/ml) for 48 h. The growth inhibition rate of the cells was measured by MTT assay, apoptosis was detected by flow cytometry, the expression levels of Shh, GLI1, E-cadherin and vimentin were detected by western blot analysis, and cell invasion and migration ability were examined by transwell cell invasion assay and wound healing assay. Following stimulation with TGF-β1, the expression levels of Shh, GLI1 and vimentin in the TGF-β1-stimulated group were significantly increased, compared with those in the control group (P<0.01, respectively). The expression levels of E-cadherin in the TGF-β1-stimulated group were significantly decreased, compared with those in the control group (P<0.01). The TGF-β1-stimulated PANC-1 cells were treated with curcumin and the results showed that curcumin significantly inhibited TGF-β1-stimulated PANC-1 cell proliferation and induced apoptosis, compared with other groups (P<0.01), and the expression levels of Shh, GLI1 and vimentin in the curcumin-treated group were significantly decreased compared with those in the control group (P<0.01, respectively). The expression level of E-cadherin in the curcumin-treated group was significantly increased compared with that in the control group (P<0.01). Cell invasion in the curcumin-treated group (30 µmol/ml) was significantly decreased compared with that in the control group (P<0.01). The scratch wounds in the curcumin-treated group healed slower compared with those in the control group (P<0.01). Curcumin significantly inhibited the invasion and migration of TGF-β1-stimulated PANC-1 cells. These results indicate that curcumin can inhibit the proliferation of TGF-β1-stimulated PANC-1 cells, it can induce apoptosis, and reverse the EMT. The possible underlying molecular mechanisms are through inhibition of the Shh-GLI1 signaling pathway.
Similar articles
-
Curcumin: a potent agent to reverse epithelial-to-mesenchymal transition.Cell Oncol (Dordr). 2019 Aug;42(4):405-421. doi: 10.1007/s13402-019-00442-2. Epub 2019 Apr 13. Cell Oncol (Dordr). 2019. PMID: 30980365 Review.
-
Curcumin inhibits hypoxia-induced epithelial‑mesenchymal transition in pancreatic cancer cells via suppression of the hedgehog signaling pathway.Oncol Rep. 2016 Jun;35(6):3728-34. doi: 10.3892/or.2016.4709. Epub 2016 Mar 28. Oncol Rep. 2016. PMID: 27035865
-
Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.BMC Cancer. 2015 Mar 5;15:97. doi: 10.1186/s12885-015-1119-y. BMC Cancer. 2015. PMID: 25884904 Free PMC article.
-
The mechanism of epithelial-mesenchymal transition induced by TGF-β1 in neuroblastoma cells.Int J Oncol. 2017 May;50(5):1623-1633. doi: 10.3892/ijo.2017.3954. Epub 2017 Apr 5. Int J Oncol. 2017. PMID: 28393230 Free PMC article.
-
Roles of Dietary Phytoestrogens on the Regulation of Epithelial-Mesenchymal Transition in Diverse Cancer Metastasis.Toxins (Basel). 2016 May 24;8(6):162. doi: 10.3390/toxins8060162. Toxins (Basel). 2016. PMID: 27231938 Free PMC article. Review.
Cited by
-
Bringing Curcumin to the Clinic in Cancer Prevention: a Review of Strategies to Enhance Bioavailability and Efficacy.AAPS J. 2017 Jan;19(1):54-81. doi: 10.1208/s12248-016-0003-2. Epub 2016 Oct 25. AAPS J. 2017. PMID: 27783266 Review.
-
Chronic Oxidative Stress Promotes Molecular Changes Associated with Epithelial Mesenchymal Transition, NRF2, and Breast Cancer Stem Cell Phenotype.Antioxidants (Basel). 2019 Dec 11;8(12):633. doi: 10.3390/antiox8120633. Antioxidants (Basel). 2019. PMID: 31835715 Free PMC article.
-
Curcumin: reclaiming the lost ground against cancer resistance.Cancer Drug Resist. 2021 Jun 19;4(2):298-320. doi: 10.20517/cdr.2020.92. eCollection 2021. Cancer Drug Resist. 2021. PMID: 35582033 Free PMC article. Review.
-
Curcumin: a potent agent to reverse epithelial-to-mesenchymal transition.Cell Oncol (Dordr). 2019 Aug;42(4):405-421. doi: 10.1007/s13402-019-00442-2. Epub 2019 Apr 13. Cell Oncol (Dordr). 2019. PMID: 30980365 Review.
-
Tetrastigma hemsleyanum (Sanyeqing) root extracts evoke S phase arrest while inhibiting the migration and invasion of human pancreatic cancer PANC-1 cells.BMC Complement Med Ther. 2024 Mar 27;24(1):133. doi: 10.1186/s12906-024-04425-1. BMC Complement Med Ther. 2024. PMID: 38539165 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous